Tratamiento del paciente pediátrico con Covid-19
DOI:
https://doi.org/10.36829/63CTS.v7i3.979Resumen
COVID-19 afecta entre el 1.2 al 5% de niños y adolescentes en diversos países incluyendo Guatemala, la mayoría con manifestaciones clínicas leves a moderadas. La terapéutica farmacológica para enfermedad grave aún no está completamente establecida, por lo que se realizó una revisión de literatura de artículos científicos publicados en revistas indizadas para proporcionar una actualización del tratamiento de COVID-19 en niños y adolescentes, que ayude a orientar las decisiones clínicas. El tratamiento de casos leves consiste en antipiréticos, antibióticos en neumonía leve; en casos moderados, monitoreo de signos vitales, cánula binasal, manejo de líquidos, antipiréticos y analgésicos, toma de hemocultivo, inicio de antibióticos y uso de beta agonistas de acción corta o esteroides inhalados. En enfermedad grave, ventilación mecánica no invasiva o invasiva, ventilación prono temprana, soporte nutricional, hídrico y vasopresor, mantenimiento del equilibrio ácido base y de electrolitos. Se indica el uso de antibióticos y antivirales como remdesivir y el manejo inmunológico con interferón alfa, esteroides y/o inmunoglobulina. Se monitorea función hepática, renal, inmunológica, hematológica y cardíaca. No se ha encontrado evidencia de que la hidroxicloroquina, ivermectina y algunos antivirales disminuyan la mortalidad en pacientes pediátricos. Actualmente no existe ningún medicamento específico, validado científicamente para el tratamiento de COVID-19 en niños. El tratamiento para casos graves se decide a partir de las experiencias del tratamiento en adultos, por lo cual es importante continuar con investigación de fármacos específicos para la población pediátrica.Descargas
Citas
Antonucci, E., Fiaccadori, E., Donadello, K., Taccone, F. S., Franchi, F., & Scolletta, S. (2014). Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment. Journal of Critical Care, 29(4), 500-511. https://doi.org/10.1016/j.jcrc.2014.03.028
Balasubramanian, S., Rao, N. M., Goenka, A., Roderick, M., & Ramanan, A. V. (2020). Coronavirus disease 2019 (COVID-19) in children - What we know so far and what we do ot. Indian Pediatrics, 57(5), 435-442. https://doi.org/10.1007/s13312-020-1819-5
Boelig, R. C., Manuck, T., Oliver, E. A., Di Mascio, D., Saccone, G., Bellussi, F., & Berghella, V. (2020). Labor and delivery guidance for COVID-19. American Journal of Obstetrics & Gynecology MFM, 2(2), Article e100110. https://doi.org/10.1016/j.ajogmf.2020.100110
Calvo, C., Garcia López-Hortelano, M., Vicente, J. C., & Martínez Vázquez, J. L. (2020). Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). Anales de Pediatria, 92(4), 241.el-241e11. https://doi.org/10.1016/j.anpedi.2020.02.001
Castagnoli, R., Votto, M., Licari, A., Brambilla, I., Bruno, R., Perlini, S., … Marseglia, G. L. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. JAMA Pediatrics, 174(9), 882-889. https://doi.org/10.1001/jamapediatrics.2020.1467
Centers for Disease Control and Prevention. (2020a). Coronavirus Disease 2019 (COVID-19): Evaluation and management considerations for neonates at risk for COVID-19. Recuperado el 22 de julio de 2020 de https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
Centers for Disease Control and Prevention. (2020b). Mantenga sanos a los niños durante el brote de COVID-19. Recuperado el 22 de julio de 2020 de https://espanol.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children.html
Centro Nacional de Equidad de Género y Salud Reproductiva. (2020). Lineamiento para la prevención y mitigación de COVID-19 en la atención del embarazo, parto, puerperio y de la persona recién nacida. Secretaría de Salud. Recuperado de https://www.gob.mx/salud/cnegsr/prensa/lineamiento-para-la-prevencion-y-mitigacion-de-covid-19-en-la-atencion-del-embarazo-parto-puerperio-y-de-la-persona-recien-nacida?idiom=es
Cruz, A. T., & Zeichner, S. L. (2020). COVID-19 in Children: Initial characterization of the pediatric disease Andrea. Pediatrics, 145(6), 6-10. https://doi.org/https://doi.org/10.1542/peds.2020-0834
de Souza, T. H., Nadal, J. A., Nogueira, R. J. N., Pereira, R. M., & Brandão, M. B. (2020). Clinical manifestations of children with COVID-19: A systematic review. Pediatric Pulmonology, 55, 1892-1899. https://doi.org/10.1002/ppul.24885
Dhochak, N., Singhal, T., Kabra, S. K., & Lodha, R. (2020). Pathophysiology of COVID-19: Why children fare better than adults? Indian Journal of Pediatrics, 87(7), 537-546. https://doi.org/10.1007/s12098-020-03322-y
Di Mascio, D., Khalil, A., Saccone, G., Rizzo, G., Buca, D., Liberati, M., … D’Antonio, F. (2020). Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis. American Journal of Obstetrics & Gynecology MFM, 2(2), Article e100107. https://doi.org/10.1016/j.ajogmf.2020.100107
Dixon, D. L., Van Tassell, B. W., Vecchié, A., Bonaventura, A., Talasaz, A., Kakavand, H., … Abbate, A. (2020). Cardiovascular considerations in treating patients with coronavirus (COVID-19). Journal of Cardiovascular Pharmacology, 75(5), 359-367. https://doi.org/10.1097/FJC.0000000000000836
Duran, P., Berman, S., Niermeyer, S., Jaenisch, T., Forster, T., Gomez, R., … Serruya, S. (2020). COVID-19 and newborn health: systematic review. Revista Panamericana de Salud Pública, 44, 1. https://doi.org/10.26633/rpsp.2020.54
Echeverri, D., Fontanilla, M., Buitrago, L., Bruchfeld, A., Carrero, J. J., Qureshi, A. R., … Xia, X. Z. (2017). The surviving sepsis campaign. Molecular Immunology, 44(2), 266-277. https://doi.org/10.1097/01.shk.0000246898.65692.34
European Centre for Disease Prevention and Control. (2020a). Epidemiology of COVID-19, Demographic profiles Children. Recuperado de https://www.ecdc.europa.eu/en/covid-19/latest-evidence/epidemiology
European Centre for Disease Prevention and Control. (2020b). Epidemiology of COVID-19. Epidemiology of COVID-19 1. Recuperado de https://www.ecdc.europa.eu/en/covid-19/latest-evidence/epidemiology
Felsenstein, S., Herbert, J. A., Mcnamara, P. S., & Hedrich, C. M. (2020). COVID-19: Immunology and treatment options. Clinical Immunology, 215, 108448. https://doi.org/10.1016/j.clim.2020.108448
Fondo de Población de las Naciones Unidas. (24 de marzo de 2020). Los adolescentes y los jóvenes y la enfermedad del coronavirus (COVID-19). Recuperado de https://www.unfpa.org/sites/default/files/resource-pdf/COVID19-TechBrief-Youth-24Mar20.pdf
Gasparyan, A. Y., Misra, D. P., Yessirkepov, M., & Zimba, O. (2020). Perspectives of immune therapy in coronavirus disease 2019. Journal of Korean Medical Science, 35(18), Article e176. https://doi.org/10.3346/JKMS.2020.35.E176
Gil, R., Jacinto, L., Lemus, P., Barillas, G., Velásquez, S., & Recinos, F. (2020). Guía de diagnóstico clínico y manejo de pacientes pediátricos sospechosos y confirmados de COVID-19. Instituto Guatemalteco de Seguridad Social. Recuperado el 22 de julio de 2020 en https://www.igssgt.org/wp-content/uploads/2020/05/Guia-de-Diagnostico-y-Manejo-de-Pacientes-Pediatricos-Sospechosos-y-confirmados-COVID-19.pdf
Gottlieb, M., & Long, B. (2020). Dermatologic manifestations and complications of COVID-19. American Journal of Emergency Medicine, 38(9), 1715-1721. https://doi.org/10.1016/j.ajem.2020.06.011
Götzinger, F., Santiago-García, B., Noguera-Julián, A., Lanaspa, M., Lancella, L., Calò Carducci, F. I., … Riordan, A. (2020). COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. The Lancet Child & Adolescent Health, 4642(20), 1-9. https://doi.org/10.1016/s2352-4642(20)30177-2
He, Y., Wang, J., Li, F., & Shi, Y. (2020). Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. Frontiers in Microbiology, 11(1302), 1-7. https://doi.org/10.3389/fmicb.2020.01302
Henry, B. M., De Oliveira, M. H. S., Benoit, S., Plebani, M., & Lippi, G. (2020). Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): A meta-analysis. Clinical Chemistry and Laboratory Medicine, 58(7), 1021-1028. https://doi.org/10.1515/cclm-2020-0369
Hong, H., Wang, Y., Chung, H. T., & Chen, C. J. (2020). Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatrics and Neonatology, 61(2), 131–132. https://doi.org/10.1016/j.pedneo.2020.03.001
Hunter, J. D., & Doddi, M. (2010). Sepsis and the heart. British Journal of Anaesthesia, 104(1), 3-11. https://doi.org/10.1093/bja/aep339
Hwang, T. J., Randolph, A.G., & Bourgeois, F. T. (2020). Inclusion of children in clinical trials of treatments for Coronavirus disease 2019 (COVID-19). JAMA Pediatrics, 174(9), 825-826. https://doi.org/10.1001/jamapediatrics.2020.1888
Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of covid-19. Viruses, 12(4), 1-17. https://doi.org/10.3390/v12040372
Jouvet, P., Thomas, N. J., Willson, D. F., Erickson, S., Khemani, R., Smith, L., … Bembea, M. (2015). Pediatric acute respiratory distress syndrome: Consensus recommendations from the pediatric acute lung injury consensus conference. Pediatric Critical Care Medicine, 16(5), 428-439. https://doi.org/10.1097/PCC.0000000000000350
Kache, S., Chisti, M. J., Gumbo, F., Mupere, E., Zhi, X., Nallasamy, K., … Carcillo, J. (2020). COVID-19 PICU guidelines: For high- and limited-resource settings. Pediatric Research. https://doi.org/10.1038/s41390-020-1053-9
Kelly, J. C., Dombrowksi, M., O’Neil-Callahan, M., Kernberg, A. S., Frolova, A. I., & Stout, M. J. (2020). False-negative testing for severe acute respiratory syndrome coronavirus 2: Consideration in obstetrical care. American Journal of Obstetrics & Gynecology MFM, Article e100130. https://doi.org/10.1016/j.ajogmf.2020.100130
Lega, S., Naviglio, S., Volpi, S., & Tommasini, A. (2020). Recent insight into SARS-COV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19. Vaccines, 8(2), 1-30. https://doi.org/10.3390/vaccines8020224
Li, H., Liu, L., Zhang, D., Xu, J., Dai, H., Tang, N., … Cao, B. (2020). SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet, 2019(20), 8-11. https://doi.org/10.1016/S0140-6736(20)30920-X
Liguoro, I., Pilotto, C., Bonanni, M., Ferrari, M. E., Pusiol, A., Nocerino, A., … Cogo, P. (2020). SARS-COV-2 infection in children and newborns: A systematic review. European Journal of Pediatrics, 179(7), 1029-1046. https://doi.org/10.1007/s00431-020-03684-7
Lin, L., Lu, L., Cao, W., & Li, T. (2020). Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia. Emerging Microbes and Infections, 9(1), 727-732. https://doi.org/10.1080/22221751.2020.1746199
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020). COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clinica Chimica Acta, 508, 254-266. https://doi.org/10.1016/j.cca.2020.05.044
Ludvigsson, J. F. (2020). Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica, International Journal of Paediatrics, 109(6), 1088-1095. https://doi.org/10.1111/apa.15270
Maggi, E., Canonica, W., & Moretta, L. (2020). COVID-19: Unanswered questions on immune response and pathogenesis. Journal of Allergy Clinical Immunology, 146(1), 18-22. https://doi.org/10.1016/j.jaci.2020.05.001
Mantovani, A., Rinaldi, E., Zusi, C., Beatrice, G., Saccomani, M. D., & Dalbeni, A. (2020). Coronavirus disease 2019 (COVID-19) in children and/or adolescents: A meta-analysis. Pediatric Research. https://doi.org/10.1038/s41390-020-1015-2
Matthay, M. A., Zemans, R. L., Zimmerman, G. A., Arabi, Y. M., Beitler, J. R., Mercat, A., … Calfee, C. S. (2018). Acute respiratory distress syndrome. Nature Reviews Disease Primers, 5(1). https://doi.org/10.1038/s41572-019-0069-0
Mayo Clinic. (2020). COVID-19 (coronavirus) en bebés y niños. Recuperado de https://www.mayoclinic.or g/es-es/diseases-conditions/coronavirus/in-depth/coronavirus-in-babies-and-children/art-20484405
Ministerio de Salud de Costa Rica. (2020). Lineamientos generales sobre lactancia materna y COVID-19. Recuperado de https://www.ministeriodesalud.go.cr/sobre_ministerio/ prensa/docs/lactancia_materna_v1_19032020.pdf
Ministerio de Salud Pública y Asistencia Social. (2020). Situación de COVID-19 en Guatemala. Recuperado el 22 julio 2020 de https://tablerocovid.mspas.gob.gt/
Moore, J. B., & June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368(6490), 473–474. https://doi.org/10.1126/science.abb8925
Naranje, K. M., Gupta, G., Singh, A., Bajpai, S., Verma, A., Jaiswal, R., … Birthare, A. (2020). Neonatal COVID-19 infection management. Journal of Neonatology, 32(1-2), 88-98. https://doi.org/10.1177/0973217920928638
Nguyen, A. A., Habiballah, S. B., Platt, C. D., Geha, R. S., Chou, J. S., & Mcdonald, D. R. (2020). Immunoglobulins in the treatment of COVID-19 infection: Proceed with caution! Clinical Immunology, 216, Article e108459. https://doi.org/10.1016/j.clim.2020.108459
Patel, N. A. (2020). Pediatric COVID-19: Systematic review of the literature. American Journal of Otolaryngology, 41(5), Article e102573. https://doi.org/10.1016/j.amjoto.2020.102573
Price, S., Singh, S., Ledot, S., Bianchi, P., Hind, M., Tavazzi, G., & Vranckx, P. (2020). Respiratory management in severe acute respiratory syndrome coronavirus 2 infection. European Heart Journal. Acute Cardiovascular Care, 9(3) 229-238. https://doi.org/10.1177/2048872620924613
Qiu, H., Wu, J., Hong, L., Luo, Y., Song, Q., & Chen, D. (2020). Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. The Lancet Infectious Diseases, 20(6), 689-696. https://doi.org/10.1016/S1473-3099(20)30198-5
Rasmussen, S. A., Smulian, J. C., Lednicky, J. A., Wen, T. S., & Jamieson, D. J. (2020). Coronavirus Disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. American Journal of Obstetrics and Gynecology, 222(5), 415-426. https://doi.org/10.1016/j.ajog.2020.02.017
Rehman, S., Majeed, T., Azam, M., Ali, U., & Sabit, H. (2020). Current scenario of COVID-19 in pediatric age group and physiology of immune and thymus response. Saudi Journal of Biological Sciences, 27(10), 2567-2573. https://doi.org/10.1016/j.sjbs.2020.05.024
Riggioni, C., Giovannini, M., Agache, Ioana., Akdis, M,. Alves-Correia, M., … Akdis, C. A.
(2020). A compendium answering 150 questions on COVID?19 and SARS?CoV?2. Allergy. 1-39. https://doi.org/10.1111/all.14449
Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, Article e102433. https://doi.org/10.1016/j.jaut.2020.102433
Safadi-Palazzi, M. A. (2020). The intriguing features of COVID-19 in children and its impact on the pandemic. Jornal de Pediatria, 96(3), 265-268. https://doi.org/10.1016/j.jped.2020.04.001
Sankar, J., Dhochak, N., Kabra, S. K., & Lodha, R. (2020). COVID-19 in children: Clinical approach and management. Indian Journal of Pediatrics, 87(6), 433-442. https://doi.org/10.1007/s12098-020-03292-1
Sanna, G., Serra, G, Bassareo, P. P., Neroni, P., Fanos, V., & Marcialis, M. A. (2020). Children’s heart and COVID-19: Up-to-date evidence in the form of a systematic review. European Journal of Pediatrics, 179, 1079-1087. https://doi.org/10.1007/s00431-020-03699-0
She, J., Liu, L., & Liu, W. (2020). COVID-19 epidemic: Disease characteristics in children. Journal of Medical Virology, 92(7), 747-754. https://doi.org/10.1002/jmv.25807
Shen, K.-L., Yang, Y.-H., Jiang, R-M., Wang, T.-Y., Zhao, D.-C., Jiang, Y., … Global Pediatric Pulmonology Alliance (2020). Updated diagnosis, treatment and prevention of COVID-19 in children: Experts’ consensus statement (condensed version of the second edition). World Journal of Pediatrics, 16(3), 232-239. https://doi.org/10.1007/s12519-020-00362-4
Szabari, M. V., Takahashi, K., Feng, Y., Locascio, J. J., Chao, W., Carter, E. A., … Musch, G. (2019). Relation between respiratory mechanics, inflammation, and survival in experimental mechanical ventilation. American Journal of Respiratory Cell and Molecular Biology, 60(2), 179-188. https://doi.org/10.1165/rcmb.2018-0100OC
Tian, D., & Ye, Q. (2020). Hepatic complications of COVID-19 and its treatment. Journal of Medical Virology, 92(10), 1818-1824. https://doi.org/10.1002/jmv.26036
Uddin, M., Mustafa, F., Rizvi, T. A., Loney, T., Al Suwaidi, H.., Al-Marzouqi, H., … Senok, A. C. (2020). SARS-CoV-2/COVID-19: Viral genomics, epidemiology, vaccines, and therapeutic interventions. Viruses, 10, 526. https://doi.org/10.3390/v12050526
U.S. Department of Health and Human Services, Food and Drug Administration, &Center for Biologics Evaluation and Research. (2020). Development and Licensure of Vaccines to Prevent COVID-19. Guidance for Industry. (FDA-2020-D-1137). Recuperado de https://www.fda.gov/media/139638/download
Velásquez-Gómez, L., Pinillos-Montenegro, N., Calderón-Rivera, V., Álvarez-Castañeda, A., & Gómez-Hernández, V. (2020). Guía de consenso para el manejo de COVID-19 en neonatos (V.02-15/06/20). Instituto Guatemalteco de Seguridad Social. Recuperado de https://www.igssgt.org/wp-content/uploads/2020/05/Guia-de-consenso-para-el-manejo-de-COVID-19-en-neonatos.pdf?=137
Wang, H., & Ma, S. (2008). The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. American Journal of Emergency Medicine, 26(6), 711-715. https://doi.org/10.1016/j.ajem.2007.10.031
Wollina, U., Karada?, A. S., Rowland-Payne, C., Chiriac, A., & Lotti, T. (2020). Cutaneous signs in COVID-19 patients: A review. Dermatologic Therapy, 2020, Article e13549, 1-6. https://doi.org/10.1111/dth.13549
World Health Organization (2020a) Management of Covid-19, Interim Guidance, 27 May 2020. World Health Organization. https://apps.who.int/iris/handle/10665/332638. License: CC BY-NC-SA 3.0 IGO
World Health Organization. (15 May 2020b). Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief. https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19
World Health Organization. (2020c). Draft landscape of COVID-19 candidate vaccines. Recuperado el 15 May 2020, de https://www.who.int/ publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
World Health Organization. (2020d). Breastfeeding and COVID-19. (WHO/2019-nCoV/SciBrief/Breastfeeding/ 2020). Recuperado de: https://www.who.int/ publications/i/item/WHO-2019-nCoV-Sci_Brief-Breastfeeding-2020.1
Yong, S. E. F., Anderson D. A. Wei, W. E., Pang, J., Chia, W. N., Tang, C. H., ...Lee, V. J. M. (2020). Connecting clusters of COVID-19: An epidemiological and serological investigation. The Lancet Infectious Diseases, 20(7), 809-815. https://doi.org/10.1016/S1473-3099(20)30273-5
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical Immunology, 215. https://doi.org/10.1016/j.clim.2020.108427
Zhang, B., Liu, S., Dong, Y., Zhang, L., Zhong, Q., Zou, Y., & Zhang, S. (2020). Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19). Journal of Infection, 81(2), 13-37. https://doi.org/10.1016/j.jinf.2020.04.023
Zimmermann, P., & Curtis, N. (2020). Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatric Infectious Disease Journal, 39(5), 355-368. https://doi.org/10.1097/INF.0000000000002660
Zullo, F., Di Mascio, D., & Saccone, G. (2020). COVID-19 antibody testing in pregnancy. American Journal of Obstetrics & Gynecology MFM, 2(3), 100142. https://doi.org/10.1016/j.ajogmf.2020.100142
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2020 Mónica E. Rosales-Salán, Aida G. Barrera-Pérez, Magda F. Velásquez-Tohom
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
El autor que publique en esta revista acepta las siguientes condiciones:
- El autor otorga a la Dirección General de Investigación el derecho de editar, reproducir, publicar y difundir el manuscrito en forma impresa o electrónica en la revista Ciencia, Tecnología y Salud.
- La Direción General de Investigación otorgará a la obra una licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional
